Our goal is to provide the cosmetic, nutraceutic and pharmaceutical industry with a unique technological platform to unravel the complexity of human adipose tissue biology and upgrafe efficacy and safety testing.
More than 30 years of known-how and knowledge of adipose tissue biology and adipose tissue R&D models lead to ExAdEx patented breakthough technology allowing to generate the first physio-pathological and clinically relevant human adipose tissue R&D models that integrate the complexity of native adipose tissue biology.
Our physiological R&D models of human adipose tissue provide an original approach for the evaluation and claim substantiation of cosmetic and nutraceutical ingredients as well as drug candidates, based on innovative and highly differentiating criteria. They allow to characterize the biological effects of the products of interest on a fully competent tissue structure ressembling the native context and evaluate their efficacy on a wide range of conditions: skin ageing, skin health, weight management, metabolic disorders, lipodystrophies, etc.
Why reproducing and mimicking human fat tissue by assembling different components in vitro or using poorly translational animal models when you can leverage what already exists in nature: the native human fat tissue?
Current R&D models for adipose tissue are poorly relevant of native physiology and pathological states, thus failing to predict target engagement and in vivo human efficacy and safety of fat-targeting drugs or compounds.
Starting from surgical waste subcutaneous fat material, ExAdEx technology allows to generate the first physiological, fully competent and clinically relevant human adipose tissue R&D models.
Our main innovation relies on the ability of adipose stem cells to proliferate in response to mechanical stimuli and the use of the native extracellular matrix as a bioactive support.
ExAdEx physiological adipose tissue models display the 3D structural and functional characteristics of native tissue:
ExAdEx technology was developed in French research excellence labs (CNRS/INSERM).